Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Particle and Fibre Toxicology
|
May 17, 2011
Subchronic inhalation toxicity of gold nanoparticles
Jae Hyuck Sung, Jun Ho Ji, Jung Duck Park, et al.
Clinical Lung Cancer
|
August 31, 2025
Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study
Niels Reinmuth, Jonathan W Goldman, Yuanbin Chen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 27, 2008
Subchronic inhalation toxicity of silver nanoparticles
Jae Hyuck Sung, Jun Ho Ji, Jung Duck Park, et al.
The Oncologist
|
July 19, 2024
Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids
Jung Hun Kang, Kyung Hee Lee, Seok Jae Huh, et al.
Histopathology
|
February 24, 2015
High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients
Seok-Hyun Kim, Jun Ho Ji, Kyung Tae Park, et al.
Cancer Research and Treatment
|
April 19, 2024
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials
Youjin Kim, Bhumsuk Keam, Eun Joo Kang, et al.
Head & Neck
|
October 13, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Dong Hyun Kim, Yoojoo Lim, Chan-Young Ock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2023
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden
Luis Paz-Ares, Marina Chiara Garassino, Yuanbin Chen, et al.
Lancet (London, England)
|
October 9, 2019
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, et al.
Cancer Research and Treatment
|
April 13, 2023
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Particle and Fibre Toxicology
|
May 17, 2011
Subchronic inhalation toxicity of gold nanoparticles
Jae Hyuck Sung, Jun Ho Ji, Jung Duck Park, et al.
Clinical Lung Cancer
|
August 31, 2025
Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study
Niels Reinmuth, Jonathan W Goldman, Yuanbin Chen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 27, 2008
Subchronic inhalation toxicity of silver nanoparticles
Jae Hyuck Sung, Jun Ho Ji, Jung Duck Park, et al.
The Oncologist
|
July 19, 2024
Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids
Jung Hun Kang, Kyung Hee Lee, Seok Jae Huh, et al.
Histopathology
|
February 24, 2015
High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients
Seok-Hyun Kim, Jun Ho Ji, Kyung Tae Park, et al.
Cancer Research and Treatment
|
April 19, 2024
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials
Youjin Kim, Bhumsuk Keam, Eun Joo Kang, et al.
Head & Neck
|
October 13, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Dong Hyun Kim, Yoojoo Lim, Chan-Young Ock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2023
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden
Luis Paz-Ares, Marina Chiara Garassino, Yuanbin Chen, et al.
Lancet (London, England)
|
October 9, 2019
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, et al.
Cancer Research and Treatment
|
April 13, 2023
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, et al.
Page
of 7